• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Syapse Appoints Former RelayHealth Executive Ken Tarkoff as New CEO

by HITC Staff 03/15/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Syapse Appoints Former RelayHealth Executive Ken Tarkoff as New CEO

Syapse, a provider of precision oncology solutions has appointed former RelayHealth executive Ken Tarkoff as its new Chief Executive Officer (CEO). As CEO, Ken will help Syapse transform health care by making precision medicine available to more patients nationwide through new and expanded partnerships with health systems and other health care stakeholders.

Previously, Ken served as Chief Operating Officer (COO) for RelayHealth and Senior Vice President and General Manager at RelayHealth after it was acquired by McKesson.  At RelayHealth, Ken launched many new innovations and scaled technology solutions in the clinical and financial decision support spaces, including co-founding and being a service provider for the CommonWell Health Alliance and leading the worldwide deployment of the Patient Centered Medical Home initiative for the U.S. Department of Defense. Previously, Ken was the Director of Supplier Services at Xign Corporation, Vice President of Product Management for Questium, and Vice President of Regional Operations at Vivra Specialty Partners.

With the adoption of precision medicine, physicians are now able to deliver personalized care that matches patients with targeted, cutting-edge therapies based on their individual genomic makeup. This change results in better care and outcomes that are ultimately more cost-effective for both patients and providers. Currently, the challenge for providers is making sense of the fragmented clinical, molecular, and outcomes data needed to deliver these treatments at scale. Syapse offers a robust platform that brings together all of this data for delivery within a physician’s workflow. The Syapse network provides physicians access to the largest, real-world precision oncology data sharing consortium in the world.

“Precision medicine has the power to transform health care, delivering better treatments and better outcomes. I’m excited to join Syapse, a company uniquely positioned to drive this transformation,” said Ken Tarkoff, Syapse’s new CEO in a statement. “With its innovative model and unmatched network, Syapse can help more physicians offer effective and cost-efficient treatments so that patients get better, faster.”

Ken joins Syapse during a period of rapid growth for the company, in offerings, customers, and capabilities. Leading health systems, including Intermountain Healthcare, Providence St. Joseph Health, Stanford Cancer Institute, Catholic Health Initiatives, Dignity Health, Henry Ford Health System, and Cancer Treatment Centers of America, have adopted Syapse to manage nearly one million active cancer cases throughout 285 hospitals across 25 states.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |